Pioneering Personalized Cell Therapies

BioGrad’s stem cell & CAR‑T cell therapy division is dedicated to developing innovative, personalized treatments in a cost-effective manner. BioGrad is working alongside UK and international government organisations to develop a range of bio-manufactured products for therapeutic use in a range of cancers and neurodegenerative disease .

Safety, Regulation & Quality

Stem cell therapies are manufactured to comply with HTA (Human Tissue Authority) regulations whilst CAR-T therapies are being developed to comply with MHRA (Medicines and Healthcare products Regulatory Agency) regulations and UK advanced therapy medicinal product (ATMP) frameworks.

All work is undertaken in Good Manufacturing Practice (GMP) certified facilities.

Research & Clinical Trials

We are committed to clinical trials to evaluate safety and efficacy through partnerships with hospitals, universities and regulatory bodies.